{
    "title": "India gives Hetero Labs and Cipla approval to make Gilead's COVID-19 drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8444777/India-gives-Hetero-Labs-Cipla-approval-make-Gileads-COVID-19-drug.html",
    "date": "2020-06-21",
    "keywords": [
        "drug",
        "covid19",
        "india",
        "market",
        "version",
        "treatment",
        "hetero",
        "cipla",
        "remdesivir",
        "licensing",
        "june",
        "regulator",
        "light",
        "brand",
        "name",
        "covifor",
        "milligram",
        "dose",
        "controller",
        "general",
        "dcgi",
        "comment",
        "gilead",
        "month",
        "pakistan",
        "supply",
        "life",
        "labs",
        "mylan",
        "nv",
        "drugmaker",
        "zydus",
        "cadila",
        "week",
        "pact",
        "record",
        "jump",
        "coronavirus",
        "saturday",
        "increase",
        "health",
        "ministry",
        "total",
        "contractor",
        "bengaluru",
        "editing",
        "clarke",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}